| API Access | |

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from Medical Ikkou Group Co.,Ltd. was processed by Pulse News Wire on April 6, 2026. It represents a primary source document for Japanese Earnings sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Medical Ikkou Group Reports FY26 Revenue of 55.0 billion, Up 14%

TOKYO, Apr 06 (Pulse News Wire) – Medical Ikkou Group Co., Ltd. (3353.T) reported consolidated results for fiscal year 2026 ending February. Revenue was ¥55.0 billion (+13.6% YoY). operating profit wa

View all Medical Ikkou Group Co.,Ltd. disclosures →

Medical Ikkou Group Co.,Ltd. [3353.T]

TOKYO, Apr 06 (Pulse News Wire) – Medical Ikkou Group Co., Ltd. (3353.T) reported consolidated results for fiscal year 2026 ending February.

Revenue was ¥55.0 billion (+13.6% YoY). operating profit was ¥2,632 million (+7.2%). net profit attributable to shareholders was ¥1,859 million (+2.4%).

Total assets stood at ¥37.5 billion with an equity ratio of 41.7%. The company declared an annual dividend of ¥60 per share. The full-year forecast for the current fiscal year is revenue of ¥28.0 billion (+4.0%).

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.

Medical Ikkou Group Reports FY26 Revenue of 55.0 billion, Up 14%

Related Disclosures